Directorate Change

Lupus Capital PLC 23 February 2004 Lupus Capital Plc Board appointment Lupus Capital plc announced today the appointment of Denis Mulhall as an Executive Director. He will join the Company and Board with immediate effect. From 1988 to 1993 Denis, 52, worked with Greg at Tomkins, the company Greg built from a market capitalisation of £6m to £5bn in 15 years. Denis left to join Berisford plc firstly as Chief Financial Officer and then Chief Operating Officer, seeing the transformation of the company from a shell to a market capitalisation of £700m. Recently he was Chief Financial Officer at Oxford GlycoSciences Plc. Commenting on the appointment, Greg Hutchings said: 'We are now building the core team of the company which will see us through to the first series of acquisitions. This is a very exciting and important time for Lupus and I am looking forward to a year of great progress.' Commenting on his appointment Denis Mulhall said: 'I am delighted to be working with Greg again. We proved what can be achieved at Tomkins where under Greg's leadership massive shareholder value was created.' Enquiries: Equity Development 020 7405 7777 / 07850 944187 Alan Frame Mr. Mulhall is a non-executive director of RingProp plc. In accordance with paragraph 16.4 of the Listing Rules, no further details regarding Mr. Mulhall are required to be disclosed under paragraph 6.F.2(b) to (g). This information is provided by RNS The company news service from the London Stock Exchange

Companies

Tyman (TYMN)
UK 100

Latest directors dealings